Oncology Trends
FDA’s Fast-Track Cancer Drug Strategy Faces a Tough Reality Check—Was the Speed Trade-Off Worth It for Patients?
2026-04-17
[Illustrations] The Diversity Deficit in Oncology Trials: When Enrollment Logic No Longer Reflects Real-World Patients
2026-04-16
AI Uncovers Adult Thymus as a Master Regulator of Cancer Immunotherapy Efficacy and Longevity
2026-04-15
The Targeted Strike – ADCs and Bispecifics Delivering Precision Payloads in Modern Oncology
2026-04-15
Global Study Reveals Rising Head and Neck Cancer Risks Among Women and Regional Disparities
2026-04-09
Gilead’s $5 Billion Bet Targets Tubulis’ Potential Best-in-Class ADC Platform in Oncology Push
2026-04-07
Reprogramming Protein Homeostasis: Lyterian’s Patient-Focused Mission to Rethink Oncology and Neurodegeneration
2026-03-03
[Illustrations] Radiopharmaceuticals in 2026: Alpha Emitters, Industrial Scale, and the Supply Chain as Strategy
2026-02-09
LATEST
Study Reveals Variability in PD-L1 Combined Positive Score Application Between Clinical Trials and Real-World Settings for Gastroesophageal Cancer
2026-04-18
Low-Temperature Drying and Airtight Packaging Found Effective for Preserving Nutrients in Bauhinia Purpurea Petals
2026-04-18
EVENT
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California





